Navigation Links
Amped Up Piezos Are On The Move - Driving Piezos with an Affordable High Voltage Piezo Amplifier QPA200
Date:2/26/2009

An affordable High Voltage Piezo Amplifier (QPA200) for driving piezoelectric transducers in industrial applications, and to facilitate transducer evaluation in a laboratory setting.

Medford, MA (PRWEB) February 26, 2009 -- Piezoelectric elements have a myriad of uses. They can be used in laser mirror alignment, or to reduce vibrations in a structure. They can be used to acoustically cancel noise, or to replace solenoid valves in controlling the flow of fluids or gases. Piezos can be driven to move air, or to stir fluids for medical or manufacturing processes. The piezos used in these applications invariably need to be driven by an amplifier.

Midé Technology's QPA200 is a hybrid amplifier consisting of a power operational amplifier coupled with an efficient, high-voltage switch mode power supply. Conor Clery, Director of Production at Midé said, "The instrument was designed as an affordable solution for driving piezoelectric transducers in industrial applications, and to facilitate transducer evaluation in a laboratory setting". It is available for bench top operation in a compact and lightweight aluminum enclosure measuring less than 9 x 9 x 4 inches with a total weight of 7 pounds (3.17kg). The simple, economical design makes the QPA200 an excellent choice for all piezoelectric applications.

The QPA200 is a high-voltage, single-channel linear amplifier specifically designed for powering piezoelectric capacitive devices, as well as Midé's product line of packaged QuickPack, and conformable PowerAct piezoelectric transducers (actuators and sensors). The instrument is configured as an inverting amplifier that offers a fixed or adjustable DC gain in the range of -10 to -100. The bipolar analog output spans +200V to -200V with an integrated current limit of +/-200mA. Additional product highlights include a large bandwidth exceeding 1kHz for typical loads, integrated thermal protection circuitry, output voltage and current monitoring functions, and an accuracy of better than 1%.

In coming months, Midé intends to release a miniaturized, low-cost version of the QPA200 that will enable new users to evaluate piezoelectric devices. The MPA400 is a high-voltage Class-D switching amplifier in a hand-held package. Similar to the QPA200, the smaller version will offer a +/-200V output, but with far greater efficiency enabled by switch-mode operation.

These instruments represent a sample of the technologies developed by Mide's capable team of electronics engineers. Since 1989, Mide engineers have been performing advanced research and development for countless applications, including: distributed wireless brake force sensors for freight trains; Volture range of piezoelectric energy harvester devices for self-powered sensors; resonant structural health monitoring; and efficient piezo valves for space and medical applications.

If you'd like more information about this topic, please visit our website www.mide.com, or to schedule an interview with Conor Clery, please call Conor at 781 306 0609 ext 292, or email Conor at cclery (at) mide.com

###

Read the full story at http://www.prweb.com/releases/piezoelectric/amplifier/prweb2183374.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Frost & Sullivan: Novel Diagnostics Methods Driving the European Cancer IVD Market Towards Early Detection and Prevention
2. Driving under the influence (of stress): Regional effects of 9/11 attacks on driving
3. MU professor recommends changing drivers perceptions of law enforcement to deter drunk driving
4. Most Important Factors Driving Usage of Antibiotics in the ICU Setting are Availability in Intravenous Formulation, Activity Against Key Gram Negative Pathogens, Drug Interactions and Bactericidal Activity
5. Driving Consumer Engagement Is Focus of Address by Healthfitness Chief Medical Officer at Watson Wyatt Health Care Solutions Event
6. Economy Driving Women to Skimp on Health Care: Poll
7. UCLA scientists find cell pathway driving a deadly sub-type of breast cancer
8. States Asleep at the Wheel in Fighting Drowsy Driving
9. AMA to Support Laws Against Text Messaging While Driving
10. Whats at Risk from Unlicensed Teen Drivers: One in 25 Admit to Driving Without a License
11. Turning Clocks Back Increases Risk of Drowsy Driving
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Amped Up Piezos Are On The Move - Driving Piezos with an Affordable High Voltage Piezo Amplifier QPA200
(Date:1/19/2017)... ... January 19, 2017 , ... MB ... a new $11,250,000 senior credit facility to Sunrise, Florida-based Management Health Systems, LLC, ... used to facilitate a recapitalization of MedPro led by Harren Equity Partners. ...
(Date:1/19/2017)... CA (PRWEB) , ... January 19, 2017 , ... ... Tranquility acoustic and privacy panel system. , The Tranquility privacy panel system ... a collaborative office environment. Tranquility panels help reduce noise and provide the visual ...
(Date:1/19/2017)... ... January 19, 2017 , ... Tribble Insurance Agency, a family owned ... region, is inaugurating a charity event to honor Chad Phillip Dermyer, a local police ... year, Chad Phillip Dermyer and his fellow officers were conducting routine stops of suspects ...
(Date:1/19/2017)... ... January 19, 2017 , ... For the second consecutive ... of Connecticut (RMACT) have earned “Top Doctor” awards. Dr. Mark Leondires, Dr. Spencer ... each been chosen by their peers for the 2017 list based on their ...
(Date:1/19/2017)... ... January 19, 2017 , ... Sales Focus Inc. (SFI), a ... the US market. , Over the past 20 years SFI has been recognized as ... has launched six new clients into the US market. The new clients include: ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... -- Accuray Incorporated (Nasdaq: ARAY ) announced ... set the bar for excellence in customer satisfaction. The ... rating among radiation treatment delivery systems in the U.S., ... Briefing™. The most recent ratings trend also shows Accuray ... for 11 of the past 12 quarters. ...
(Date:1/19/2017)... 19, 2017 Shire plc (LSE: ... U.S. Food and Drug Administration (FDA) has acknowledged receipt ... Application (NDA) for SHP465, a long-acting, triple-bead, mixed amphetamine ... once-daily treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). The FDA is ... 20, 2017, the designated Prescription Drug User Fee Act ...
(Date:1/19/2017)... The global  pacemaker market  is expected to reach USD ... Inc. The heightening prevalence of cardiac conditions coupled with the availability of medical ... addition, technological enhancements in these devices are supporting the expansion of this vertical. ... ... Grand View Research Logo ...
Breaking Medicine Technology: